Altogether, differential SUMO2 proteomic profiling identified various targets of PML NBs in treated APL and mESCs, not only KAP1 and its interacting chromatin-remodeling partners, but also key transcription regulators, suggesting a broad role of PML in epigenetic and transcriptional regulation. The gene discussed is PML; the disease is acute promyelocytic leukemia.